Stocktoria
Minerva Neurosciences, Inc. NERV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-06-25
Minerva Neurosciences, Inc. statistics & valuation
Market cap$203.6M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -299.5% | 3.9% | -52.7% | -58.3% | -64.7% |
| Return on equity | 208.5% | -5.6% | 105.4% | 160.3% | -625.7% |
| Current ratio | 36.28 | 7.85 | 12.57 | 29.15 | 22.07 |
| Revenue growth | — | — | — | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001598646 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.